Answers are grounded in this paper and cite their sources.
This investigation reveals metabolic dysfunctions in Barth syndrome-related cardiomyopathy, suggesting potential therapeutic targets.
, which leads to immature cardiolipin (CL) remodeling and is characterized by the development of cardiomyopathy. The immature CL remodeling in BTHS results in electron transport chain respiratory defects and destabilization of supercomplexes, thereby impairing ATP production. Thus, BTHS-related cardiomyopathy appears to share metabolic characteristics of the failing heart being an "engine out of fuel." As CL associates with numerous mitochondrial enzymes involved in ATP production, BTHS is also characterized by several defects in intermediary energy metabolism. Herein we will describe the primary disturbances in intermediary energy metabolism relating to the heart's major fuel sources, fatty acids, carbohydrates, ketones, and amino acids. In addition, we will interrogate whether these disturbances represent potential metabolic targets for alleviating BTHS-related cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Greenwell et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: